ANDREOZZI, Francesco
 Distribuzione geografica
Continente #
NA - Nord America 6.794
AS - Asia 3.975
EU - Europa 2.000
SA - Sud America 956
Continente sconosciuto - Info sul continente non disponibili 256
AF - Africa 92
OC - Oceania 15
Totale 14.088
Nazione #
US - Stati Uniti d'America 6.536
SG - Singapore 1.775
IT - Italia 914
CN - Cina 867
BR - Brasile 733
VN - Vietnam 467
IN - India 349
DE - Germania 299
GB - Regno Unito 180
SE - Svezia 168
CA - Canada 132
FI - Finlandia 120
BD - Bangladesh 117
HK - Hong Kong 116
AR - Argentina 103
MX - Messico 51
RU - Federazione Russa 48
ID - Indonesia 45
NL - Olanda 42
FR - Francia 40
EC - Ecuador 39
ES - Italia 35
IQ - Iraq 33
PL - Polonia 31
TR - Turchia 29
ZA - Sudafrica 27
PK - Pakistan 25
UA - Ucraina 23
JP - Giappone 22
CO - Colombia 21
CL - Cile 17
EE - Estonia 16
GT - Guatemala 14
IL - Israele 14
VE - Venezuela 14
CZ - Repubblica Ceca 13
IR - Iran 13
AU - Australia 12
KE - Kenya 12
PY - Paraguay 12
UZ - Uzbekistan 12
CR - Costa Rica 11
ET - Etiopia 11
JO - Giordania 11
SV - El Salvador 11
SA - Arabia Saudita 10
UY - Uruguay 10
AE - Emirati Arabi Uniti 9
AT - Austria 9
MA - Marocco 9
MT - Malta 9
EG - Egitto 8
HN - Honduras 8
IE - Irlanda 7
KR - Corea 7
KZ - Kazakistan 7
PH - Filippine 7
JM - Giamaica 6
PR - Porto Rico 6
RO - Romania 6
CH - Svizzera 5
GR - Grecia 5
PE - Perù 5
SC - Seychelles 5
SN - Senegal 5
TT - Trinidad e Tobago 5
TW - Taiwan 5
AL - Albania 4
DZ - Algeria 4
KG - Kirghizistan 4
LK - Sri Lanka 4
MK - Macedonia 4
MY - Malesia 4
NO - Norvegia 4
SY - Repubblica araba siriana 4
AM - Armenia 3
CW - ???statistics.table.value.countryCode.CW??? 3
DO - Repubblica Dominicana 3
EU - Europa 3
LB - Libano 3
LV - Lettonia 3
NG - Nigeria 3
NI - Nicaragua 3
TN - Tunisia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AO - Angola 2
AZ - Azerbaigian 2
BG - Bulgaria 2
BH - Bahrain 2
BY - Bielorussia 2
GA - Gabon 2
GP - Guadalupe 2
HU - Ungheria 2
MD - Moldavia 2
OM - Oman 2
SI - Slovenia 2
TH - Thailandia 2
AG - Antigua e Barbuda 1
AW - Aruba 1
BA - Bosnia-Erzegovina 1
Totale 13.821
Città #
San Jose 1.301
Singapore 638
Ashburn 575
Chandler 470
Dallas 434
Santa Clara 367
Council Bluffs 283
Bengaluru 266
Hefei 262
Milan 230
Munich 227
Princeton 178
Lawrence 176
Ho Chi Minh City 169
Chicago 165
Beijing 159
London 131
Hong Kong 111
Wilmington 108
Hanoi 107
Phoenix 99
Los Angeles 96
Boardman 83
São Paulo 72
New York 68
Ottawa 64
Teverola 59
Turku 54
Des Moines 53
Helsinki 53
Rome 52
Aversa 40
Catanzaro 37
The Dalles 32
Shanghai 30
Columbus 27
Rio de Janeiro 26
Warsaw 24
Orem 22
Atlanta 21
Haiphong 21
Boston 20
Brooklyn 20
Hanover 20
Denver 19
Tokyo 19
Assago 18
Buffalo 18
Palermo 18
Amsterdam 17
Baghdad 17
Mexico City 16
Naples 16
San Francisco 16
Da Nang 15
Toronto 15
Charlotte 14
Chennai 14
Johannesburg 14
Alessandria 13
Buenos Aires 13
Dhaka 13
Guatemala City 13
Montreal 13
Ninh Bình 13
Olomouc 13
Redmond 13
Biên Hòa 12
Brasília 12
Guangzhou 12
Guayaquil 12
Norwalk 12
Pune 12
Salvador 12
Campinas 11
Guarulhos 11
Jakarta 11
Quito 11
Tashkent 11
Thái Bình 11
Turin 11
Cosenza 10
Curitiba 10
Latina 10
Manchester 10
Stockholm 10
Addis Ababa 9
Frankfurt am Main 9
Messina 9
Nairobi 9
Philadelphia 9
Rende 9
San José 9
Teresina 9
Amman 8
Ann Arbor 8
Belo Horizonte 8
Brattirò 8
Can Tho 8
Genoa 8
Totale 8.131
Nome #
Association between higher duodenal levels of the fructose carrier glucose transporter-5 and nonalcoholic fatty liver disease and liver fibrosis 220
Early molecular and behavioral response to lipopolysaccharide in the WAG/Rij rat model of absence epilepsy and depressive-like behavior, involves interplay between AMPK, AKT/mTOR pathways and neuroinflammatory cytokine release 161
Higher serum levels of uric acid are associated with a reduced insulin clearance in non-diabetic individuals 130
Angiotensin II type 1 receptor, but no type 2 receptor, interferes with the insulin-induced nitric oxide production in HUVECs. 110
3'-UTR OLR1/LOX-1 gene polymorphism and endothelial dysfunction: molecular and vascular data in never-treated hypertensive patients 94
C-174G polymorphism in the promoter of the interleukin-6 gene is associated with insulin resistance 93
Positive association between plasma IGF1 and high-density lipoprotein cholesterol levels in adult nondiabetic subjects 91
A functional variant of the dimethylarginine dimethylaminohydrolase-2 gene is associated with insulin sensitivity 88
Angiotensin II impairs the insulin signaling pathway promoting production of nitric oxide by inducing phosphorylation of insulin receptor substrate-1 on Ser312 and Ser616 in human umbilical vein endothelial cells 87
Association between hemoglobin glycation index and hepatic steatosis in non-diabetic individuals 85
A network-based analysis of genes related to comorbidities in diabetes 84
Vitamin D Serum Levels in Subjects Tested for SARS-CoV-2: What Are the Differences among Acute, Healed, and Negative COVID-19 Patients? A Multicenter Real-Practice Study 84
Alkaline phosphatase affects renal function in never-treated hypertensive patients: effect modification by age 83
Increased carotid intima-media thickness in the physiologic range is associated with impaired postprandial glucose metabolism, insulin resistance and beta cell dysfunction 82
A functional variant of the dimethylarginine dimethylaminohydrolase-2 gene is associated with chronic kidney disease. 82
Depressed myocardial mechano-energetic efficiency in subjects with dysglycemia 82
Metabolites profiling of melanoma interstitial fluids reveals uridine diphosphate as potent immune modulator capable of limiting tumor growth 82
Augmented duodenal levels of sodium/glucose co-transporter 1 are associated with higher risk of nonalcoholic fatty liver disease and noninvasive index of liver fibrosis 81
Characterization of left ventricular mass in individuals at risk for type 2 diabetes identified by HbA1c levels according to the American Diabetes Association criteria 81
Augmented duodenal levels of sodium/glucose co-transporter 1 are associated with higher risk of nonalcoholic fatty liver disease and noninvasive index of liver fibrosis. 81
A polymorphism at IGF1 locus is associated with anemia. 80
Uric acid and vascular damage in essential hypertension: Role of insulin resistance 80
Association between serum Mg2+ concentrations and cardiovascular organ damage in a cohort of adult subjects 79
Elevated one-hour post-load plasma glucose levels identifies subjects with normal glucose tolerance but early carotid atherosclerosis 78
Association between hemoglobin glycation index with insulin resistance and carotid atherosclerosis in non-diabetic individuals. 77
Cardiovascular and Renal Outcomes with Efpeglenatide in Type 2 Diabetes 77
Association between a genetic variant related to glutamic acid metabolism and coronary heart disease in individuals with type 2 diabetes. 76
A functional variant of the dimethylarginine dimethylaminohydrolase-2 gene is associated with myocardial infarction in type 2 diabetic patients 76
Liraglutide prevents cognitive decline in a rat model of streptozotocin-induced diabetes independently from its peripheral metabolic effects 75
Are Circulating Mg2+ Levels Associated with Glucose Tolerance Profiles and Incident Type 2 Diabetes? 75
Duodenal Sodium/Glucose Cotransporter 1 Expression Under Fasting Conditions Is Associated With Postload Hyperglycemia. 75
The TRIB3 R84 variant is associated with increased left ventricular mass in a sample of 2426 White individuals 75
Endothelial dysfunction and C-reactive protein are risk factors for diabetes in essential hypertension 74
A fasting insulin-raising allele at IGF1 locus is associated with circulating levels of IGF-1 and insulin sensitivity 74
Effects of Intermittent Pneumatic Compression on Lower Limb Lymphedema in Patients with Type 2 Diabetes Mellitus: A Pilot Randomized Controlled Trial 74
Depressed myocardial mechano-energetic efficiency in subjects with dysglycemia 73
Short term effect of sacubitril/valsartan on comprehensive geriatric assessment in chronic heart failure: a real life analysis 72
A polymorphism at IGF1 locus is associated with carotid intima media thickness and endothelium-dependent vasodilatation. 72
Chronic hyperglycemia impairs insulin secretion by affecting insulin receptor expression, splicing, and signaling in RIN beta cell line and human islets of Langerhans 72
Effects of Sacubitril-Valsartan on Clinical, Echocardiographic, and Polygraphic Parameters in Patients Affected by Heart Failure With Reduced Ejection Fraction and Sleep Apnea 71
Long-term benefits of dapagliflozin on renal outcomes of type 2 diabetes under routine care: a comparative effectiveness study on propensity score matched cohorts at low renal risk 71
One-Hour Postload Plasma Glucose Levels Are Associated with Kidney Dysfunction 71
Carotid artery intima-media thickness is associated with insulin-mediated glucose disposal in nondiabetic normotensive offspring of type 2 diabetic patients 70
Ferritin modifies the relationship between inflammation and arterial stiffness in hypertensive patients with different glucose tolerance 70
One-hour post-load hyperglycemia combined with HbA1c identifies individuals with augmented duodenal levels of sodium/glucose co-transporter 1 69
The Triglycerides and Glucose (TyG) Index Is Associated with 1-Hour Glucose Levels during an OGTT 68
SRT1720 counteracts glucosamine-induced endoplasmic reticulum stress and endothelial dysfunction 68
Joint effect of insulin signaling genes on insulin secretion and glucose homeostasis 68
Neutrophil degranulation biomarkers characterize restrictive echocardiographic pattern with diastolic dysfunction in patients with diabetes 68
One-hour post-load glucose levels are associated with hepatic steatosis assessed by transient elastography 67
Association between right ventricular dysfunction and adverse cardiac events in mild COPD patients 67
Glucagon induces the hepatic expression of inflammatory markers in vitro and in vivo 66
Sex-differences in insulin sensitivity and insulin secretion in subjects with impaired fasting glucose and impaired glucose tolerance 65
Prevalence of hepatic steatosis in patients with type 2 diabetes and response to glucose-lowering treatments. A multicenter retrospective study in Italian specialist care 65
One-hour post-load hyperglycemia combined with HbA1c identifies individuals with higher risk of cardiovascular diseases: Cross-sectional data from the CATAMERI study 65
Angiotensin (1-7) counteracts the negative effect of angiotensin II on insulin signalling in HUVECs. 65
Altered glucose metabolism and vascular function 65
Functional importance of Insulin-Like Growth Factor I receptor COOH-terminal region tyrosine phosphorylation sites 65
Exenatide regulates pancreatic islet integrity and insulin sensitivity in the nonhuman primate baboon Papio hamadryas. 64
Analysis of age-dependent gene-expression in human tissues for studying diabetes comorbidities 63
Effects of 26 weeks of treatment with empagliflozin versus glimepiride on the myocardial glucose metabolic rate in patients with type 2 diabetes: The randomized, open-label, crossover, active-comparator FIORE trial 63
Uric Acid Is Associated With Inflammatory Biomarkers and Induces Inflammation Via Activating the NF-κB Signaling Pathway in HepG2 Cells 63
The Functional Polymorphism of DDAH2 rs9267551 Is an Independent Determinant of Arterial Stiffness. 63
Body mass index versus surrogate measures of central adiposity as independent predictors of mortality in type 2 diabetes 63
Prognostic role of serum albumin levels in patients with chronic heart failure 62
Unfavorable inflammatory profile in adults at risk of type 2 diabetes identified by hemoglobin A1c levels according to the American Diabetes Association criteria 62
Reciprocal association of plasma IGF-1 and interleukin-6 levels with cardiometabolic risk factors in nondiabetic subjects 62
ANGIOTENSIN II IMPAIRS THE INSULIN SIGNALING PATHWAY PROMOTING PRODUCTION OF NITRIC OXIDE BY INDUCING PHOSPHORYLATION OF IRS- 1 ON SER312 AND SER616 IN HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS 62
Activation of the hexosamine pathway leads to phosphorylation of insulin receptor substrate-1 on Ser307 and Ser612 and impairs the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin insulin biosynthetic pathway in RIN pancreatic beta-cells 62
HDL (High-Density Lipoprotein) and ApoA-1 Potentially Modulate Pancreatic α-Cell Glucagon Secretion 62
Impaired insulin-stimulated myocardial glucose metabolic rate is associated with reduced estimated myocardial energetic efficiency in subjects with different degrees of glucose tolerance 61
Association between augmented levels of the gut pro-hormone Proneurotensin and subclinical vascular damage 61
Endothelial dysfunction is associated with reduced myocardial mechano-energetic efficiency in drug-naïve hypertensive individuals. 61
Statins, ACE/ARBs drug use, and risk of pneumonia in hospitalized older patients: a retrospective cohort study 61
Reduction in Global Myocardial Glucose Metabolism in Subjects With 1-Hour Postload Hyperglycemia and Impaired Glucose Tolerance 61
Sex-specific differences in left ventricular mass and myocardial energetic efficiency in non-diabetic, pre-diabetic and newly diagnosed type 2 diabetic subjects 61
Elevated 1-h post-load plasma glucose is associated with right ventricular morphofunctional parameters in hypertensive patients. 60
Prognostic role of short physical performance battery in elderly hospitalized atrial fibrillation patients 58
Insulin-like growth factor-1 and glomerular filtration rate in hypertensive patients 58
Higher circulating levels of proneurotensin are associated with increased risk of incident NAFLD 57
Relationship between hemoglobin glycation index and myocardial mechano-energetic efficiency in non-diabetic individual 57
The polymorphism rs35767 at IGF1 locus is associated with serum urate levels 57
Increased O-glycosylation of insulin signaling proteins results in their impaired activation and enhanced susceptibility to apoptosis in pancreatic beta-cells 57
HDL cholesterol is an independent predictor of β-cell function decline and incident type 2 diabetes: A longitudinal study 57
Low circulating insulin-like growth factor-1 levels are associated with high serum uric acid in nondiabetic adult subjects 56
Elevated hemoglobin glycation index identify non-diabetic individuals at increased risk of kidney dysfunction 56
One-hour post-load hyperglycemia is a stronger predictor of type 2 diabetes than impaired fasting glucose 56
Contribution of ONECUT1 variants to different forms of non-autoimmune diabetes mellitus in Italian patients 55
Differential network analysis between sex of the genes related to comorbidities of type 2 mellitus diabetes 55
Long-term cognitive function changes with non-vitamin K oral anticoagulants in older patients with atrial fibrillation. A multicenter cohort study 55
Competitive interaction between smoking and chronic obstructive pulmonary disease for explaining renal function reduction in hypertensive patients 55
Plasma kisspeptin levels are associated with insulin secretion in nondiabetic individuals. 55
Endothelial dysfunction, ADMA and insulin resistance in essential hypertension 55
Endothelial dysfunction and non-alcoholic liver steatosis in hypertensive patients 55
Different Patterns of Left Ventricular Hypertrophy in Metabolically Healthy and Insulin-Resistant Obese Subjects 55
Low Insulin-Like Growth Factor-1 Levels Are Associated With Myocardial Mechano-Energetic Efficiency in Older Individuals 54
Transposition of cardiovascular outcome trial effects to the real-world population of patients with type 2 diabetes 54
THE E23K VARIANT OF KCNJ11 ENCODING THE PANCREATIC Β-CELL KATP CHANNEL SUBUNITS KIR6.2 IS ASSOCIATED WITH AN INCREASED RISK OF SECONDARY FAILURE TO SULFONYLUREA IN PATIENTS WITH TYPE 2 DIABETES 54
Glucagon-like peptide-1 receptor agonists and atrial fibrillation: a systematic review and meta-analysis of randomised controlled trials. 54
Impact of common polymorphisms in candidate genes for insulin resistance and obesity on weight loss of morbidly obese subjects after laparoscopic adjustable gastric banding and hypocaloric diet 54
Totale 7.155
Categoria #
all - tutte 130.005
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 130.005


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022534 0 0 0 115 69 8 20 117 47 78 77 3
2022/20231.482 364 27 42 132 176 121 40 138 204 92 107 39
2023/2024986 155 134 58 66 75 172 37 111 17 17 73 71
2024/20252.868 366 120 134 89 245 357 153 116 314 125 319 530
2025/20266.517 344 662 821 1.084 628 248 760 373 752 476 227 142
2026/20271.408 64 311 684 349 0 0 0 0 0 0 0 0
Totale 14.088